Baird Downgrades Tenet Healthcare (THC) to Neutral

Baird analyst Michael Ha downgraded Tenet Healthcare (NYSE: THC) from Outperform to Neutral with a price target of $137.00 (from $153.00).

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $124.91 yesterday.

You May Also Be Interested In

• Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
• Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
• Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities